IDEAYA Biosciences annual operating margin
2020
2021
2022
2023
2024
2025
IDEAYA Biosciences's operating margin was −72.84% for fiscal 2025.
View full IDEAYA Biosciences company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −72.84% | +4598.23 pp |
| 2024 | 2024-12-31 | −4,671.07% | −4096.22 pp |
| 2023 | 2023-12-31 | −574.85% | −452.13 pp |
| 2022 | 2022-12-31 | −122.72% | +57.19 pp |
| 2021 | 2021-12-31 | −179.91% | +0.99 pp |
| 2020 | 2020-12-31 | −180.90% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −1,380.73% | −312.28 pp |
| Q1 2026 | 2026-03-31 | −1,654.63% | −1237.54 pp |
| Q3 2025 | 2025-09-30 | 52.18% | +975.12 pp |
| Q4 2024 | 2024-12-31 | −2,059.11% | −1725.62 pp |
| Q4 2023 | 2023-12-31 | −1,068.44% | −410.98 pp |
| Q3 2023 | 2023-09-30 | −417.09% | −419.32 pp |
| Q2 2023 | 2023-06-30 | −922.94% | −538.41 pp |
| Q1 2023 | 2023-03-31 | −333.49% | −208.30 pp |
| Q4 2022 | 2022-12-31 | −657.46% | −37.30 pp |
| Q3 2022 | 2022-09-30 | 2.22% | +132.71 pp |
| Q2 2022 | 2022-06-30 | −384.53% | −258.32 pp |
| Q1 2022 | 2022-03-31 | −125.19% | +0.87 pp |
| Q4 2021 | 2021-12-31 | −620.16% | −564.44 pp |
| Q3 2021 | 2021-09-30 | −130.49% | — |
| Q2 2021 | 2021-06-30 | −126.21% | — |
| Q1 2021 | 2021-03-31 | −126.05% | — |
| Q3 2020 | 2020-09-30 | −55.72% | — |
Over the last five reported fiscal years, IDEAYA Biosciences's operating margin increased from −180.90% to −72.84%, a change of +108.06 percentage points. The latest reported quarter, Q2 2026, shows −1,380.73%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review IDEAYA Biosciences filings at SEC.gov ↗